Treatment of Ethylene Glycol Poisoning with Intravenous 4-Methylpyrazole

New England Journal of Medicine

Volumn 319, Issue 2, 1988, Pages 97-100

  Baud, Frédéric J ^a   Galliot, Martine ^a   Astier, Alain ^a   Bien, Dang vu ^a   Garnier, Robert ^a   Likforman, Joseph ^a   Bismuth, Chantal ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLPYRAZOLE; ACTIVATED CARBON; ALCOHOL; BICARBONATE; ETHYLENE GLYCOL;

ADULT; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SUICIDE;

EID: 0023880624     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198807143190206     Document Type: Article

References (43)

1. Theorell H, Yonetani T. On the effects of some heterocyclic compounds on the enzymatic activity of liver alcohol dehydrogenase. Acta Chem Scand 1969; 23: 255–60.
2. Li T-K, Theorell H. Human liver alcohol dehydrogenase: inhibition by pyrazole and pyrazole analogs. Acta Chem Scand 1969; 23: 892–902.
3. Makar AB, Tephly TR. Inhibition of monkey liver alcohol dehydrogenase by 4-methylpyrazole. Biochem Med 1975; 13: 334–42.
4. Pietruszko R. Human liver alcohol dehydrogenase — inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. Biochem Pharmacol 1975; 24: 1603–7.
5. Blomstrand R, Östling-Wintzell H, Löf A, McMartin K, Tolf B-R, Hedström K-G. Pyrazoles as inhibitors of alcohol oxidation and as important tools in alcohol research: an approach to therapy against methanol poisoning. Proc Natl Acad Sci USA 1979; 76: 3499–503.
6. Blomstrand R, Theorell H. Inhibitory effect on ethanol oxidation in man after administration of 4-methylpyrazole. Life Sci [Part 2] 1970; 9: 631–40.
7. Blomstrand R, Kager L. The combustion of triolein-l-14C and its inhibition by alcohol in man. Life Sci 1973; 13: 113–23.
8. Salaspuro MP, Pikkarainen P, Lindros K. Ethanol-induced hypoglycaemia in man: its suppression by the alcohol dehydrogenase inhibitor 4-methylpyrazole. Eur J Clin Invest 1977; 7: 487–90.
9. Salaspuro MP, Lindros KO, Pikkarainen PH. Effect of 4-methylpyrazole on ethanol elimination rate and hepatic redox changes in alcoholics with adequate or inadequate nutrition and in nonalcoholic controls. Metabolism 1978; 27: 631–9.
10. Lindros KO, Stowell A, Pikkarainen P, Salaspuro M. The disulfiram (Antabuse)-alcohol reaction in male alcoholics: its efficient management by 4-methylpyrazole. Alcoholism (NY) 1981; 5: 528–30.
11. Kupari M, Lindros K, Hillbom M, Heikkilä J, Ylikahri R. Cardiovascular effects of acetaldehyde accumulation after ethanol ingestion: their modification by β-adrenergic blockade and alcohol dehydrogenase inhibition. Alcoholism (NY) 1983; 7: 283–8.
12. Clay KL, Murphy RC. On the metabolic acidosis of ethylene glycol intoxication. Toxicol Appl Pharmacol 1977; 39: 39–49.
13. Chou JY, Richardson KE. The effect of pyrazole on ethylene glycol toxicity and metabolism in the rat. Toxicol Appl Pharmacol 1978; 43: 33–44.
14. Grauer GF, Thrall MAH, Henre BA, Hjelle JJ. Comparison of the effects of ethanol and 4-methylpyrazole on the pharmacokinetics and toxicity of ethylene glycol in the dog. Toxicol Lett 1987; 35: 307–14.
15. McMartin KE, Hedström K-G, Tolf B-R, Östling-Wintzell H, Blomstrand R. Studies on the metabolic interactions between 4-methylpyrazole and methanol using the monkey as an animal model. Arch Biochem Biophys 1980; 199: 606–14.
16. Magnusson G, Nyberg J-A, Bodin N-O, Hansson E. Toxicity of pyrazole and 4-methylpyrazole in mice and rats. Experientia 1972; 28: 1198–200.
17. Kager L, Ericsson JLE. Long term toxicity study with alcohol and 4-methylpyrazole in rat. Acta Pathol Microbiol Scand [A] 1974; 82: 534–8.
18. Blomstrand R, Ellin Å, Löf A, Östling-Wintzell H. Biological effects and metabolic interactions after chronic and acute administration of 4-methylpyrazole and ethanol to rats. Arch Biochem Biophys 1980; 199: 591–605.
19. Lindros KO, Sipponen P, Pikkarainen P, Turunen U, Salaspuro M. Alcoholic liver damage is provoked by 4-methylpyrazole, which prolongs the influence of ethanol but reduces acetaldehyde levels. Alcoholism (NY) 1979; 3: 78–82.
20. McMartin KE, Jacobsen D, Sebastian S, Barron SK, Blomstrand R. Safety and metabolism of 4-methylpyrazole in human subjects. Vet Hum Toxicol 1987; 29: 471. abstract.
21. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings: mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1986; 1: 309–34.
22. Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA. Methanol and ethylene glycol. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Kulberg AG, eds. Toxicologic emergencies. 3rd ed. Norwalk, Conn.: Appleton-Century-Crofts, 1986:452–67.
23. Baud FJ, Bismuth C, Garnier R, et al. 4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in man. J Toxicol Clin Toxicol 1986–87; 24: 463–83.
24. Harger RN, Forney RB. A simple method for detecting and estimating ethylene glycol in body materials; analytical results in six fatal cases. J Forensic Sci 1959; 4: 136–43.
25. Nash T. Colorimetric determination of formaldehyde under mild conditions. Nature 1952; 170: 976.
26. Peterson CD, Collins AJ, Himes JM, Bullock ML, Keane WF. Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med 1981; 304: 21–3.
27. Jacobsen D, Bredesen JE, Eide I, Østborg J. Anion and osmolal gaps in the diagnosis of methanol and ethylene glycol poisoning. Acta Med Scand 1982; 212: 17–20.
28. Jacobsen D, Øvreb⊘ S, Østborg J, Sejersted OM. Glycolate causes the acidosis in ethylene glycol poisoning and is effectively removed by hemodialysis. Acta Med Scand 1984; 216: 409–16.
29. Duburque MT, Melon JM, Thomas J, et al. Dosage et identification de l'acide oxalique dans les milieux biologiques. Ann Biol Clin (Paris) 1970; 28: 95–101.
30. Ellenhorn MJ, Barceloux DG, eds. Medical toxicology. New York: Elsevier, 1988:805–9.
31. Spector R, ed. The scientific basis of clinical pharmacology. Boston: Little, Brown, 1986:231–50.
32. Goldberg L, Rydberg U. Inhibition of ethanol metabolism in vivo by administration of pyrazole. Biochem Pharmacol 1969; 18: 1749–62.
33. Jacobsen D, Barron SK, McMartin KE, Sebastian S, Blomstrand R. Single dose pharmacokinetics of 4-methylpyrazole in humans. Fed Proc 1987; 46: 868. abstract.
34. Zahlten RN. Ethanol for ethylene glycol poisoning. N Engl J Med 1981; 304: 977.
35. Cheng J-T, Beysolow TD, Kaul B, Weisman R, Feinfeld DA. Clearance of ethylene glycol by kidneys and hemodialysis. J Toxicol Clin Toxicol 1987; 25: 95–108.
36. Parry MF, Wallach R. Ethylene glycol poisoning. Am J Med 1974; 57: 143–50.
37. Underwood F, Bennett WM. Ethylene glycol intoxication: prevention of renal failure by aggressive management. JAMA 1973; 226: 1453–4.
38. Stokes JB III, Aueron F. Prevention of organ damage in massive ethylene glycol ingestion. JAMA 1980; 243: 2065–6.
39. Wacker WEC, Haynes H, Druyan R, Fisher W, Coleman JE. Treatment of ethylene glycol poisoning with ethyl alcohol. JAMA 1965; 194: 1231–3.
40. Brown CG, Trumbull D, Klein-Schwartz W, Walker JD. Ethylene glycol poisoning. Ann Emerg Med 1983; 12: 501–6.
41. Holman NW Jr, Mundy RL, Teague RS. Alkyldiol antidotes to ethylene glycol toxicity in mice. Toxicol Appl Pharmacol 1979; 49: 385–92.
42. Murphy MJ, Ray achéal, Jones LP, Reagor JC. 1,3 Butanediol treatment of ethylene glycol toxicosis in dogs. Am J Vet Res 1984; 45: 2293–5.
43. Wilson WL, Bottiglieri NG. Phase I studies with pyrazole. Cancer Chemother Rep 1962; 21: 137–41.